HK Stock MarketDetailed Quotes

02367 GIANT BIOGENE

Watchlist
  • 50.250
  • +1.700+3.50%
Market Closed May 3 16:09 CST
50.00BMarket Cap31.21P/E (TTM)

GIANT BIOGENE Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax
48.17%1.75B
51.16%775.58M
21.05%1.18B
--513.09M
-0.03%972.92M
43.76%973.24M
--677M
Profit adjustment
Interest (income) - adjustment
-260.90%-47.49M
-256.57%-23.76M
-39.87%-13.16M
---6.66M
4.80%-9.41M
38.93%-9.88M
---16.18M
Impairment and provisions:
11.09%521K
157.66%316K
139.29%469K
---548K
110.72%196K
-216.20%-1.83M
--1.57M
-Impairmen of inventory (reversal)
942.07%1.22M
261.60%648K
-11.54%-145K
---401K
-120.00%-130K
18.18%650K
--550K
-Impairment of trade receivables (reversal)
81.38%-27K
-6.31%-337K
-402.08%-145K
---317K
-80.41%48K
-25.30%245K
--328K
-Other impairments and provisions
-188.67%-673K
-97.06%5K
173.02%759K
--170K
110.21%278K
-491.38%-2.72M
--696K
Revaluation surplus:
-454.17%-29.33M
-391.41%-15.19M
157.21%8.28M
--5.21M
90.65%-14.47M
-95,441.98%-154.78M
---162K
-Other fair value changes
-454.17%-29.33M
-391.41%-15.19M
157.21%8.28M
--5.21M
90.65%-14.47M
-95,441.98%-154.78M
---162K
Asset sale loss (gain):
-1.30%2.88M
-16.95%2.37M
1,501.10%2.91M
--2.86M
-21.55%182K
4,540.00%232K
--5K
-Loss (gain) on sale of property, machinery and equipment
-1.30%2.88M
-16.95%2.37M
720.85%2.91M
--2.86M
53.02%355K
4,540.00%232K
--5K
-Loss (gain) from selling other assets
----
----
----
----
---173K
----
----
Depreciation and amortization:
23.70%34.18M
21.00%16.87M
14.12%27.63M
--13.94M
8.61%24.21M
24.66%22.29M
--17.88M
-Depreciation
24.63%32.65M
21.88%16.13M
14.41%26.2M
--13.24M
8.54%22.9M
25.50%21.09M
--16.81M
-Amortization of intangible assets
6.56%1.53M
4.55%735K
9.06%1.43M
--703K
9.77%1.31M
11.45%1.2M
--1.07M
Financial expense
433.33%112K
--57K
--21K
----
----
----
----
Exchange Loss (gain)
-107.55%-1.09M
-904.39%-15.04M
166.86%14.45M
--1.87M
---21.61M
----
----
Special items
16.16%20.52M
26.47%10.43M
7.13%17.66M
--8.25M
2,684.97%16.49M
--592K
----
Operating profit before the change of operating capital
39.59%1.73B
39.71%751.63M
27.62%1.24B
--538.01M
16.71%968.5M
22.02%829.87M
--680.11M
Change of operating capital
Inventory (increase) decrease
81.17%-17.77M
54.41%-3.24M
-283.44%-94.36M
---7.12M
-70.38%-24.61M
-50.53%-14.44M
---9.6M
Accounts receivable (increase)decrease
-796.09%-32.58M
-333.20%-21.26M
67.43%-3.64M
--9.12M
-112.96%-11.16M
293.19%86.12M
---44.58M
Accounts payable increase (decrease)
280.67%119.14M
389.98%55.53M
292.22%31.3M
--11.33M
-134.11%-16.28M
92.49%47.74M
--24.8M
prepayments (increase)decrease
155.59%34.32M
108.91%11.16M
-219.48%-61.75M
---125.18M
-309.23%-19.33M
-84.70%9.24M
--60.37M
Cash  from business operations
67.81%1.85B
89.45%794.18M
21.27%1.1B
--419.21M
-4.67%910.66M
33.42%955.26M
--715.96M
Other taxs
-19.14%-205.76M
6.04%-101.29M
20.87%-172.7M
---107.8M
-80.18%-218.26M
-103.57%-121.13M
---59.51M
Special items of business
864.41%24.7M
105.34%372K
-123.87%-3.23M
---6.96M
514.93%13.54M
-167.22%-3.26M
--4.85M
Net cash from operations
76.83%1.65B
122.50%692.9M
34.55%931.64M
--311.41M
-16.99%692.4M
27.06%834.12M
--656.46M
Cash flow from investment activities
Interest received - investment
260.90%47.49M
256.57%23.76M
39.87%13.16M
--6.66M
-4.80%9.41M
-38.93%9.88M
--16.18M
Loan receivable (increase) decrease
----
----
----
----
-13.33%201.31M
1,364.34%232.27M
--15.86M
Sale of fixed assets
----
--50K
----
----
----
----
----
Purchase of fixed assets
-48.24%-226.3M
-338.82%-186.96M
-103.55%-152.66M
---42.61M
0.67%-75M
11.66%-75.51M
---85.47M
Selling intangible assets
----
----
----
----
--16.53M
----
----
Purchase of intangible assets
-263.99%-2.13M
----
98.38%-586K
---526K
-4,286.91%-36.19M
97.20%-825K
---29.44M
Sale of subsidiaries
--33.13M
--33.13M
----
----
----
----
----
Recovery of cash from investments
-54.15%678.83M
5.25%603.92M
-72.44%1.48B
--573.81M
22.17%5.37B
346.80%4.4B
--984.2M
Cash on investment
51.88%-1.06B
-32.70%-946.3M
43.97%-2.2B
---713.1M
22.80%-3.93B
-240.96%-5.08B
---1.49B
Net cash from investment operations
38.60%-527.28M
-168.78%-472.4M
-154.93%-858.74M
---175.76M
399.98%1.56B
11.65%-521.12M
---589.85M
Net cash before financing
1,436.56%1.12B
62.55%220.49M
-96.77%72.9M
--135.65M
620.65%2.26B
369.90%313.01M
--66.61M
Cash flow from financing activities
Issuing shares
----
----
1,023,592.98%583.51M
----
--57K
----
----
Dividends paid - financing
----
----
85.59%-367.46M
---367.46M
-169,335.22%-2.55B
---1.51M
----
Absorb investment income
-96.38%8.9M
-98.35%4M
-96.53%245.89M
--241.89M
78,723.44%7.09B
50.00%9M
--6M
Issuance expenses and redemption of securities expenses
99.80%-12.44M
99.80%-12.44M
-1,990,828.66%-6.25B
---6.24B
---314K
----
----
Other items of the financing business
29,859.14%55.35M
---531K
99.73%-186K
----
-173.04%-68.31M
-206.44%-25.02M
---8.16M
Net cash from financing operations
100.89%51.81M
99.86%-8.98M
-229.36%-5.79B
---6.36B
25,640.97%4.48B
-709.75%-17.52M
---2.16M
Effect of rate
101.98%1.09M
135.33%15.04M
-1,485.12%-55.18M
---42.57M
--3.98M
----
----
Net Cash
120.50%1.17B
103.40%211.52M
-184.93%-5.72B
---6.23B
2,178.04%6.73B
358.49%295.48M
--64.45M
Begining period cash
-81.26%1.33B
-81.26%1.33B
1,831.19%7.1B
--7.1B
408.56%367.81M
818.27%72.32M
--7.88M
Cash at the end
88.14%2.5B
86.60%1.56B
-81.26%1.33B
--834.69M
1,831.19%7.1B
408.56%367.81M
--72.32M
Cash balance analysis
Cash and cash equivalent balance
--0
--0
--0
--0
--0
--0
--0
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
Ernst & Young
Ernst & Young
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax 48.17%1.75B51.16%775.58M21.05%1.18B--513.09M-0.03%972.92M43.76%973.24M--677M
Profit adjustment
Interest (income) - adjustment -260.90%-47.49M-256.57%-23.76M-39.87%-13.16M---6.66M4.80%-9.41M38.93%-9.88M---16.18M
Impairment and provisions: 11.09%521K157.66%316K139.29%469K---548K110.72%196K-216.20%-1.83M--1.57M
-Impairmen of inventory (reversal) 942.07%1.22M261.60%648K-11.54%-145K---401K-120.00%-130K18.18%650K--550K
-Impairment of trade receivables (reversal) 81.38%-27K-6.31%-337K-402.08%-145K---317K-80.41%48K-25.30%245K--328K
-Other impairments and provisions -188.67%-673K-97.06%5K173.02%759K--170K110.21%278K-491.38%-2.72M--696K
Revaluation surplus: -454.17%-29.33M-391.41%-15.19M157.21%8.28M--5.21M90.65%-14.47M-95,441.98%-154.78M---162K
-Other fair value changes -454.17%-29.33M-391.41%-15.19M157.21%8.28M--5.21M90.65%-14.47M-95,441.98%-154.78M---162K
Asset sale loss (gain): -1.30%2.88M-16.95%2.37M1,501.10%2.91M--2.86M-21.55%182K4,540.00%232K--5K
-Loss (gain) on sale of property, machinery and equipment -1.30%2.88M-16.95%2.37M720.85%2.91M--2.86M53.02%355K4,540.00%232K--5K
-Loss (gain) from selling other assets -------------------173K--------
Depreciation and amortization: 23.70%34.18M21.00%16.87M14.12%27.63M--13.94M8.61%24.21M24.66%22.29M--17.88M
-Depreciation 24.63%32.65M21.88%16.13M14.41%26.2M--13.24M8.54%22.9M25.50%21.09M--16.81M
-Amortization of intangible assets 6.56%1.53M4.55%735K9.06%1.43M--703K9.77%1.31M11.45%1.2M--1.07M
Financial expense 433.33%112K--57K--21K----------------
Exchange Loss (gain) -107.55%-1.09M-904.39%-15.04M166.86%14.45M--1.87M---21.61M--------
Special items 16.16%20.52M26.47%10.43M7.13%17.66M--8.25M2,684.97%16.49M--592K----
Operating profit before the change of operating capital 39.59%1.73B39.71%751.63M27.62%1.24B--538.01M16.71%968.5M22.02%829.87M--680.11M
Change of operating capital
Inventory (increase) decrease 81.17%-17.77M54.41%-3.24M-283.44%-94.36M---7.12M-70.38%-24.61M-50.53%-14.44M---9.6M
Accounts receivable (increase)decrease -796.09%-32.58M-333.20%-21.26M67.43%-3.64M--9.12M-112.96%-11.16M293.19%86.12M---44.58M
Accounts payable increase (decrease) 280.67%119.14M389.98%55.53M292.22%31.3M--11.33M-134.11%-16.28M92.49%47.74M--24.8M
prepayments (increase)decrease 155.59%34.32M108.91%11.16M-219.48%-61.75M---125.18M-309.23%-19.33M-84.70%9.24M--60.37M
Cash  from business operations 67.81%1.85B89.45%794.18M21.27%1.1B--419.21M-4.67%910.66M33.42%955.26M--715.96M
Other taxs -19.14%-205.76M6.04%-101.29M20.87%-172.7M---107.8M-80.18%-218.26M-103.57%-121.13M---59.51M
Special items of business 864.41%24.7M105.34%372K-123.87%-3.23M---6.96M514.93%13.54M-167.22%-3.26M--4.85M
Net cash from operations 76.83%1.65B122.50%692.9M34.55%931.64M--311.41M-16.99%692.4M27.06%834.12M--656.46M
Cash flow from investment activities
Interest received - investment 260.90%47.49M256.57%23.76M39.87%13.16M--6.66M-4.80%9.41M-38.93%9.88M--16.18M
Loan receivable (increase) decrease -----------------13.33%201.31M1,364.34%232.27M--15.86M
Sale of fixed assets ------50K--------------------
Purchase of fixed assets -48.24%-226.3M-338.82%-186.96M-103.55%-152.66M---42.61M0.67%-75M11.66%-75.51M---85.47M
Selling intangible assets ------------------16.53M--------
Purchase of intangible assets -263.99%-2.13M----98.38%-586K---526K-4,286.91%-36.19M97.20%-825K---29.44M
Sale of subsidiaries --33.13M--33.13M--------------------
Recovery of cash from investments -54.15%678.83M5.25%603.92M-72.44%1.48B--573.81M22.17%5.37B346.80%4.4B--984.2M
Cash on investment 51.88%-1.06B-32.70%-946.3M43.97%-2.2B---713.1M22.80%-3.93B-240.96%-5.08B---1.49B
Net cash from investment operations 38.60%-527.28M-168.78%-472.4M-154.93%-858.74M---175.76M399.98%1.56B11.65%-521.12M---589.85M
Net cash before financing 1,436.56%1.12B62.55%220.49M-96.77%72.9M--135.65M620.65%2.26B369.90%313.01M--66.61M
Cash flow from financing activities
Issuing shares --------1,023,592.98%583.51M------57K--------
Dividends paid - financing --------85.59%-367.46M---367.46M-169,335.22%-2.55B---1.51M----
Absorb investment income -96.38%8.9M-98.35%4M-96.53%245.89M--241.89M78,723.44%7.09B50.00%9M--6M
Issuance expenses and redemption of securities expenses 99.80%-12.44M99.80%-12.44M-1,990,828.66%-6.25B---6.24B---314K--------
Other items of the financing business 29,859.14%55.35M---531K99.73%-186K-----173.04%-68.31M-206.44%-25.02M---8.16M
Net cash from financing operations 100.89%51.81M99.86%-8.98M-229.36%-5.79B---6.36B25,640.97%4.48B-709.75%-17.52M---2.16M
Effect of rate 101.98%1.09M135.33%15.04M-1,485.12%-55.18M---42.57M--3.98M--------
Net Cash 120.50%1.17B103.40%211.52M-184.93%-5.72B---6.23B2,178.04%6.73B358.49%295.48M--64.45M
Begining period cash -81.26%1.33B-81.26%1.33B1,831.19%7.1B--7.1B408.56%367.81M818.27%72.32M--7.88M
Cash at the end 88.14%2.5B86.60%1.56B-81.26%1.33B--834.69M1,831.19%7.1B408.56%367.81M--72.32M
Cash balance analysis
Cash and cash equivalent balance --0--0--0--0--0--0--0
Currency Unit CNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor Ernst & Young--Ernst & Young--Ernst & YoungErnst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg